Steward Partners Investment Advisory, LLC Fate Therapeutics Inc Transaction History

Steward Partners Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.24 - $11.12 $784 - $2,057	185 New	185 $1,000
Q2 2022 Aug 04, 2022	SELL	$17.78 - $42.39 $1,600 - $3,815	-90 Reduced 32.73%	185 $5,000
Q1 2022 May 02, 2022	BUY	$29.67 - $60.28 $4,747 - $9,644	160 Added 139.13%	275 $11,000
Q4 2021 Feb 08, 2022	BUY	$47.84 - $64.34 $1,196 - $1,608	25 Added 27.78%	115 $7,000
Q3 2021 Nov 12, 2021	BUY	$59.27 - $95.73 $5,334 - $8,615	90 New	90 $5,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.